Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Minute Insight: Medtronic May Sell Respiratory And Monitoring Units To Private Equity

Executive Summary

Reuters reported that global private equity firm Carlyle Group has offered to pay at least $7bn for Medtronic’s patient monitoring and respiratory interventions businesses. Medtronic announced its plan to get out of those businesses about one year ago.

You may also be interested in...



Medtronic Cuts Away More: Spins Off Patient Monitoring And Respiratory Business

Medtronic announced plans to spin off its patient monitoring and respiratory interventions businesses, which currently provide revenues of over $2bn a year. The company previously signaled plans to make significant changes to its business portfolio.

Minute Insight: Amazon Gives Up On Amazon Care, Shifts Focus To Acquisitions

According to multiple reports, Amazon will wind down Amazon Care, a hybrid virtual/in-home care service, by the end of the year. The company is now focused on building a health care organization through acquisitions.

Minute Insight: Quidel And Labcorp Finish Big Year For IVD Deals With Major Acquisitions

Quidel will pay $6bn for Ortho Clinical Diagnostics. Labcorp will acquire Personal Genome Diagnostics for $575m.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT148314

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel